SCHEDULE 13G/A: Wellington Management Entities Disclose 6.6% Passive Stake in Myriad Genetics, Inc.
Beneficial Ownership Disclosure
Wellington Management Group LLP and its affiliated entities have filed an amended Schedule 13G, reporting a 6.6% beneficial ownership stake in Myriad Genetics, Inc. as of December 31, 2024.
Summary
- Wellington Management Group LLP, along with Wellington Group Holdings LLP, Wellington Investment Advisors Holdings LLP, and Wellington Management Company LLP, collectively reported beneficial ownership of 6,004,598 shares of Myriad Genetics, Inc. common stock.
- This aggregate amount represents 6.6% of Myriad Genetics, Inc.'s outstanding common stock.
- The reporting entities hold shared voting power over 4,668,873 shares and shared dispositive power over 6,004,598 shares.
- The filing is an Amendment No. 3 to a Schedule 13G, indicating a previous disclosure of beneficial ownership.
- The securities are held in the ordinary course of business and not for the purpose of changing or influencing the control of Myriad Genetics, Inc.
Sentiment
Score: 5
Explanation: The document is a factual disclosure of beneficial ownership, indicating a neutral sentiment as it does not contain performance data, strategic updates, or forward-looking statements from the issuer.
Future Outlook
NA
Management Comments
- The reporting persons certify that, to the best of their knowledge and belief, the securities were acquired and are held in the ordinary course of business.
- The securities were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities.
- The securities were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under Rule 240.14a-11.
Industry Context
NA
Key Dates
| Date | Description |
|---|---|
| 12/31/2024 | Date of event which requires the filing of this statement, representing the beneficial ownership position. |
| 02/10/2025 | Date of filing and signature for the Schedule 13G Amendment No. 3. |
Keywords
Myriad Genetics Inc., Wellington Management Group, Schedule 13G, Beneficial Ownership, Common Stock, SEC Filing, Investment Management, Passive Investment
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.